Matinas Biopharma (MTNB) Stock Chart & Stock Price History $0.98 -0.02 (-1.55%) As of 09:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Matinas Biopharma Stock Price Performance The Matinas Biopharma (MTNB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 91.18%. In the past month, the stock has increased 4.68%, reflecting recent market activity. As of the latest close, Matinas Biopharma traded at $0.99 with a market cap of $5.04 million and volume of 39,575 shares. Five years ago, the stock traded at $0.80, representing a 22.64% increase over that period. At the time, it had a market cap of $152.01 million and a volume of 4.05 million shares. Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.34%1 Month Performance+4.68%3 Month Performance+72.57%Year-To-Date Performance+91.18%5 Year Performance+22.64% MTNB Stock Chart for Wednesday, July, 16, 2025 MTNB Chart by TradingView Matinas Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$1.00$0.99-0.96%$0.99$0.9739,575 shs$5.04 million07/14/2025$1.03$1.00-2.91%$1.03$0.9642,001 shs$5.09 million07/11/2025$1.03$1.03$1.04$1.0072,716 shs$5.24 million07/10/2025$0.99$1.03+4.04%$1.04$0.9575,159 shs$5.24 million07/09/2025$0.95$0.99+4.17%$1.05$0.9592,304 shs$5.04 million07/08/2025$0.92$0.95+3.30%$1.00$0.90126,980 shs$4.84 million07/07/2025$0.91$0.92+0.77%$0.95$0.9049,053 shs$4.68 million07/04/2025$0.91$0.91$0.94$0.9114,981 shs$4.64 million07/03/2025$0.94$0.91-2.87%$0.94$0.9114,981 shs$4.64 million07/02/2025$0.90$0.94+4.09%$0.94$0.9074,422 shs$4.78 million Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$0.89$0.90+1.47%$0.94$0.8839,018 shs$4.59 million06/30/2025$0.92$0.89-3.27%$0.93$0.8962,865 shs$4.53 million06/27/2025$0.94$0.92-2.32%$0.94$0.9162,206 shs$4.68 million06/26/2025$0.96$0.94-2.29%$0.96$0.91121,199 shs$4.79 million06/25/2025$0.91$0.96+6.41%$1.04$0.88534,991 shs$4.90 million06/24/2025$0.88$0.91+2.94%$0.94$0.8756,703 shs$4.61 million06/23/2025$0.91$0.88-3.59%$0.91$0.8748,090 shs$4.48 million06/20/2025$0.90$0.91+1.44%$0.95$0.8792,990 shs$4.64 million06/19/2025$0.90$0.90$0.94$0.8985,285 shs$4.58 million06/18/2025$0.91$0.90-1.54%$0.94$0.8985,285 shs$4.58 million06/17/2025$0.93$0.91-1.87%$0.99$0.88234,662 shs$4.65 million06/16/2025$0.84$0.93+10.88%$1.19$0.844.20 million shs$4.74 million Related Companies CING Stock Price Chart MRKR Stock Price Chart BIVI Stock Price Chart QTTB Stock Price Chart MTEX Stock Price Chart PRPH Stock Price Chart RVPH Stock Price Chart CARM Stock Price Chart LPCN Stock Price Chart GELS Stock Price Chart Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:MTNB) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matinas Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Matinas Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MTNB Stock Alerts